BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10883268)

  • 1. [Immunization of mice with plasmid DNA against malaria and regulation of antigen expression by tetracycline-controlled promoter].
    Xie WK; Chen QY; Wang QB; Pan WQ; Yan RH; Lu DR
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):13-6. PubMed ID: 10883268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary study on regulable DNA vaccines against Plasmodium falciparum].
    Lei JC; Miao J; Li X; Schonig K; Bujard H; Xue CF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):356-9. PubMed ID: 15193238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral immune response in mice to hybrid nucleic acid vaccines containing Plasmodium falciparum merozoite surface protein 1 block 17-based gene].
    Miao J; Li X; Xue C; Zhen R; Liu Z; Qin E; Yu Q
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):302-4. PubMed ID: 12563865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced immunogenicity of DNA vaccine plasmids in mixtures.
    Sedegah M; Charoenvit Y; Minh L; Belmonte M; Majam VF; Abot S; Ganeshan H; Kumar S; Bacon DJ; Stowers A; Narum DL; Carucci DJ; Rogers WO
    Gene Ther; 2004 Mar; 11(5):448-56. PubMed ID: 14973538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA vaccine of Plasmodium falciparum: immune response of BALB/c mice induced by injection of the recombinant plasmid DNA].
    Li X; Yu X; Luo S; Xu J; Chen G
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(4):241-5. PubMed ID: 12078250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
    Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA/MVA combined immunization: antibody response to Plasmodium falciparum merozoite surface protein 1 in mice].
    Li SM; Li X; Xue CF; Miao J; Lei JC; Liu ZX; Wang XF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Apr; 23(2):93-6. PubMed ID: 16042175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
    Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination of mice with recombinant nucleic acid vaccine encoding the integral membrane protein Sj23 and cytokine IL-12 elicits specific immune responses against schistosoma japonica].
    Gan Y; Shi YE; Bu LY; Ning CX; Zhu HG
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):193-8. PubMed ID: 15854467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.
    Wang R; Richie TL; Baraceros MF; Rahardjo N; Gay T; Banania JG; Charoenvit Y; Epstein JE; Luke T; Freilich DA; Norman J; Hoffman SL
    Infect Immun; 2005 May; 73(5):2863-72. PubMed ID: 15845492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of immune responses elicited by recombinant protein and eukaryotic expression plasmid based on histidine rich protein 2 of Plasmodium falciparum].
    Li X; Miao J; Xue CF; Zhen RF; Liu ZX; Wang XF; Mu SJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(1):7-10. PubMed ID: 12572014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation.
    Dobaño C; Widera G; Rabussay D; Doolan DL
    Vaccine; 2007 Sep; 25(36):6635-45. PubMed ID: 17669562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.